Andelyn Biosciences

Research, Biotechnology, Pharmaceuticals, Gene therapy, Biological sciences

Founded in 2020

Columbus, Ohio

http://www.andelynbio.com

None

About Andelyn Biosciences

Andelyn Biosciences is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™. Capabilities span viral vector and vaccine process and analytical development, small to large scale adherent and suspension based GMP drug substance manufacturing up to 2000L, and finished drug product manufacturing services located in Columbus, OH USA. Having 20+ years of experience with viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with troubleshooting / characterization expertise and GMP material produced for over 75+ worldwide clinical trials. In addition to producing over 400+ cGMP clinical batches and 2000+ research-grade productions, Andelyn currently provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing (early 2022), advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Its state-of-the-art 185,000 sq ft clinical and commercial manufacturing facility comprises 14+ upstream production suites for customization of new programs and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients

Company Metrics

Employees: 101-250
Monthly Visits: None
Tech Stack: None active products

Financial Information

Estimated Revenue: $1M to $10M
Total Funding: None None
Last Funding: None None (None)
Funding Status: None

Technology Stack

Andelyn Biosciences actively uses None products in their tech stack.

Market Presence

Industries: Research, Biotechnology, Pharmaceuticals, Gene therapy, Biological sciences

Headquarters: Columbus, Ohio

Employees